EP PerMed
The European Partnership for Personalised Medicine (EP PerMed) aims to improve future healthcare for all citizens through personalised therapy, diagnosis and prevention. Funded under Horizon Europe, EP PerMed was launched in late 2023 and will run for ten years, bringing together more than 50 partners from EU and partner countries.
The partnership is coordinated by the German Aerospace Center DLR. The Finnish partners are the Research Council of Finland and Business Finland.
More information
- European Partnership for Personalised Medicine
- The first EP PerMed joint transnational call (JTC2024) is open between 12 January and 5 March 2024. See all call guidance on the partnership’s website at eppermed.eu/jtc2024
- Questions: helpdesk
